Literature DB >> 901082

Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in a health screen.

T Christensson, K Hellström, B Wengle.   

Abstract

Twenty patients being treated with thiazides were found among 95 subjects (21%) with hyercalcemia verified in repeated determinations in a health screening of 15,903 persons. There were 1,034 patients treated with thiazides in this total health screening. The prevalence of hypercalcemia in the patients treated with thiazides in this total health screening. The prevalence of hypercalcemia in the patients treated with thiazide (1.9%) was considerably higher than the prevalence of hypercalcemia found in the entire health-screened population (0.6%). The thiazide treatment was withdrawn in the 20 hypercalcemic subjects after an examination, and the patients were observed at intervals during a follow-up period of one year. The necks of 14 were explored during or after the follow-up period because of an initial serum calcium level greater than 3.0 mmole/liter or persistent hypercalcemia. Parathyroid adenomas were seen in all patients receiving surgery. Single adenomas predominated in surgical findings. The finding of the present high number of patients with primary hyperparathyroidism may be associated with elevated blood pressure resulting in thiazide treatment after detection.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901082     DOI: 10.1001/archinte.137.9.1138

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

1.  Thiazide therapy and severe hypercalcemia in a patient with hyperparathyroidism.

Authors:  P Strong; S Jewell; J Rinker; D Hoch; L Crapo
Journal:  West J Med       Date:  1991-03

2.  Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades.

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Prabin Thapa; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  J Clin Endocrinol Metab       Date:  2016-01-11       Impact factor: 5.958

3.  Bedside assessment of hypercalcaemia.

Authors:  F P Muldowney; R Freaney; M J McKenna
Journal:  Ir J Med Sci       Date:  1988-11       Impact factor: 1.568

4.  ACP Broadsheet no 144: July 1994. The investigation of hypercalcaemia. Association of Clinical Pathologists.

Authors:  P L Selby; P H Adams
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

5.  Mild asymptomatic hyperparathyroidism.

Authors: 
Journal:  Br Med J       Date:  1980-07-19

6.  The clinical features of covert diuretic use.

Authors:  D I Spratt; A Pont
Journal:  West J Med       Date:  1982-10

7.  Incidence and clinical spectrum of thiazide-associated hypercalcemia.

Authors:  Robert A Wermers; Ann E Kearns; Gregory D Jenkins; L Joseph Melton
Journal:  Am J Med       Date:  2007-04-16       Impact factor: 4.965

8.  Primary hyperparathyroidism in Austria: results of an 8-year prospective study.

Authors:  B Niederle; L Stamm; F Längle; E Schubert; W Woloszczuk; R Prager
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

Review 9.  Calcium Transport in the Kidney and Disease Processes.

Authors:  Ramy M Hanna; Rebecca S Ahdoot; Kamyar Kalantar-Zadeh; Lena Ghobry; Ira Kurtz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.